Bajaj Finserv Healthcare Fund
- NAV as on 24 Sep 2026
- ₹11.84-1.09%1 day
- Return since launch
- 10.4%
- 52-week range
- ₹8.97 — ₹12.08
- AUM
- ₹406 Cr
Bajaj Finserv Healthcare Fund is a Sectoral-Pharma equity fund from Bajaj Finserv Mutual Fund with ₹406 Cr under management, launched in 2024. The expense ratio is 2.59% and the SEBI riskometer reading is Very High.
Performance
Bajaj Finserv Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +22.3% against +17.6% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 35.3% | +16.3 pts | 19.0% | 26.9% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 0.8% | −0.2 pts | 0.9% | 0.9% |
| 3M | 9.7% | +2.3 pts | 7.4% | 7.1% |
| 6M | 27.9% | +6.2 pts | 21.7% | 20.5% |
| 1Y | 22.3% | +3.3 pts | 19.0% | 17.6% |
Since launch (6 Dec 2024): 10.4%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -4.6% | −2.5 pts | -2.0% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.59%
Expense ratio as on 23 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 2.09%
- Brokerage
- 0.04%
- Transaction charges
- 0.00%
- Statutory levies
- 0.46%
- Exit load
- 1% for redemption within 3 Months
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
Portfolio
Bajaj Finserv Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity96.0%
- Debt3.5%
- Other0.6%
Market cap split
- Large32.5%
- Mid26.6%
- Small40.9%
- P/E
- 51.44
- P/B
- 6.35
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Divi's Laboratories Ltd. | Healthcare | 10.55% | ₹42.82 Cr | +9.07% | +9.21% | +7.86% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 8.21% | ₹33.31 Cr | +6.54% | +8.40% | +7.21% |
| Rubicon Research Ltd. | Healthcare | 6.81% | ₹27.66 Cr | +4.52% | +3.70% | — |
| Piramal Pharma Ltd. | Healthcare | 6.72% | ₹27.27 Cr | +6.51% | +6.21% | +3.02% |
| Aurobindo Pharma Ltd. | Healthcare | 6.18% | ₹25.09 Cr | +6.17% | +5.93% | +2.69% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 6.00% | ₹24.34 Cr | +6.73% | +6.80% | +6.29% |
| Torrent Pharmaceuticals Ltd. | Healthcare | 5.03% | ₹20.43 Cr | +5.26% | +5.46% | +1.36% |
| Neuland Laboratories Ltd. | Healthcare | 4.11% | ₹16.66 Cr | +4.39% | +3.40% | +3.25% |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.84% | ₹15.59 Cr | +4.18% | +3.79% | +3.45% |
| Max Healthcare Institute Ltd. | Healthcare | 3.35% | ₹13.59 Cr | +3.68% | +4.40% | +1.22% |
| Others | Others | 2.73% | ₹11.15 Cr | +3.06% | +1.44% | +4.02% |
| Fortis Healthcare Ltd. | Healthcare | 2.69% | ₹10.90 Cr | +3.36% | +3.60% | +3.51% |
| Zydus Lifesciences Ltd. | Healthcare | 2.56% | ₹10.41 Cr | +1.46% | — | — |
| Ipca Laboratories Ltd. | Healthcare | 2.46% | ₹9.97 Cr | +2.31% | +2.45% | +2.11% |
| Laurus Labs Ltd. | Healthcare | 2.36% | ₹9.58 Cr | +2.05% | — | — |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 2.31% | ₹9.37 Cr | +2.43% | +1.97% | +1.88% |
| Zydus Wellness Ltd. | Consumer Staples | 2.27% | ₹9.20 Cr | +2.65% | +2.00% | +1.68% |
| Senores Pharmaceuticals Ltd. | Healthcare | 2.15% | ₹8.73 Cr | +2.05% | — | — |
| Shaily Engineering Plastics Ltd. | Materials | 2.00% | ₹8.12 Cr | +2.23% | +1.54% | +1.67% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 1.79% | ₹7.26 Cr | +1.58% | +1.94% | +1.69% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 1.70% | ₹6.88 Cr | +1.90% | +1.88% | +2.85% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.68% | ₹6.82 Cr | +1.70% | +1.57% | +3.34% |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 1.41% | ₹5.74 Cr | +1.91% | +1.98% | +1.98% |
| company:728 | Healthcare | 1.39% | ₹5.64 Cr | — | +1.02% | +5.61% |
| Bajaj Finserv Money Market Fund Direct-Growth | Unclassified | 1.30% | ₹5.28 Cr | +1.55% | +1.62% | — |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 1.28% | ₹5.19 Cr | — | — | +3.44% |
| Biocon Ltd. | Healthcare | 1.16% | ₹4.72 Cr | +1.48% | +1.42% | +3.45% |
| Navin Fluorine International Ltd. | Chemicals | 0.99% | ₹4.00 Cr | +2.14% | +1.99% | — |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 0.93% | ₹3.78 Cr | +1.14% | +1.18% | — |
| Turtlemint Fintech Solutions Ltd. | Financial | 0.92% | ₹3.74 Cr | — | — | — |
| Medi Assist Healthcare Services Ltd. | Services | 0.82% | ₹3.31 Cr | +1.12% | +1.18% | +1.54% |
| Onesource Specialty Pharma Ltd. | Healthcare | 0.82% | ₹3.34 Cr | — | — | — |
| Jubilant Pharmova Ltd. | Healthcare | 0.76% | ₹3.09 Cr | +1.05% | +0.96% | +1.08% |
| MTAR Technologies Ltd. | Capital Goods | 0.26% | ₹1.06 Cr | +0.59% | — | — |
| Sumitomo Chemical India Ltd. | Chemicals | 0.25% | ₹1.03 Cr | — | — | — |
| company:15616 | Chemicals | 0.21% | ₹0.85 Cr | — | — | +0.40% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| company:728 | 0.00% | 1.39% | +1.39% |
| Zydus Lifesciences Ltd. | 1.33% | 2.56% | +1.23% |
| Navin Fluorine International Ltd. | 2.01% | 0.99% | -1.02% |
| Others | 1.15% | 2.12% | +0.97% |
| Divi's Laboratories Ltd. | 9.67% | 10.55% | +0.88% |
| Rubicon Research Ltd. | 6.01% | 6.81% | +0.80% |
| Sun Pharmaceutical Industries Ltd. | 8.87% | 8.21% | -0.66% |
| Emcure Pharmaceuticals Ltd. | 4.37% | 3.84% | -0.53% |
| Apollo Hospitals Enterprise Ltd. | 6.50% | 6.00% | -0.50% |
| Torrent Pharmaceuticals Ltd. | 5.48% | 5.03% | -0.45% |
| Max Healthcare Institute Ltd. | 3.80% | 3.35% | -0.45% |
| Zydus Wellness Ltd. | 2.66% | 2.27% | -0.39% |
| Fortis Healthcare Ltd. | 3.01% | 2.69% | -0.32% |
| Neuland Laboratories Ltd. | 4.42% | 4.11% | -0.31% |
| Sanofi Consumer Healthcare India Ltd. | 1.70% | 1.41% | -0.29% |
| company:15616 | 0.00% | 0.21% | +0.21% |
| Krishna Institute of Medical Sciences Ltd | 1.07% | 0.93% | -0.14% |
| Medi Assist Healthcare Services Ltd. | 0.96% | 0.82% | -0.14% |
| Biocon Ltd. | 1.29% | 1.16% | -0.13% |
| Onesource Specialty Pharma Ltd. | 0.95% | 0.82% | -0.13% |
| Ipca Laboratories Ltd. | 2.34% | 2.46% | +0.12% |
| Piramal Pharma Ltd. | 6.60% | 6.72% | +0.12% |
| Glaxosmithkline Pharmaceuticals Ltd. | 1.68% | 1.79% | +0.11% |
| Jubilant Pharmova Ltd. | 0.87% | 0.76% | -0.11% |
| Vijaya Diagnostic Centre Ltd. | 2.20% | 2.31% | +0.11% |
| Dr. Lal Pathlabs Ltd. | 1.78% | 1.68% | -0.10% |
| Dr. Reddy's Laboratories Ltd. | 1.37% | 1.28% | -0.09% |
| Turtlemint Fintech Solutions Ltd. | 0.83% | 0.92% | +0.09% |
| Bajaj Finserv Money Market Fund Direct-Growth | 1.39% | 1.30% | -0.09% |
| Glenmark Pharmaceuticals Ltd. | 1.64% | 1.70% | +0.06% |
| Laurus Labs Ltd. | 2.41% | 2.36% | -0.05% |
| Aurobindo Pharma Ltd. | 6.13% | 6.18% | +0.05% |
| Senores Pharmaceuticals Ltd. | 2.11% | 2.15% | +0.04% |
| MTAR Technologies Ltd. | 0.23% | 0.26% | +0.03% |
| Shaily Engineering Plastics Ltd. | 2.02% | 2.00% | -0.02% |
| Sumitomo Chemical India Ltd. | 0.27% | 0.25% | -0.02% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,579 Cr | 2.19% | 27.6% | 18.0% | 20.3% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.4% | 14.4% | 19.6% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.3% | 20.2% | 22.4% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 31.0% | 18.9% | 20.0% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.9% | 19.5% | 21.3% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.6% | 17.0% | 18.0% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund managers
- Siddharth ChaudharyMr. Chaudhary is a B.Com (H) and PGDM (Securities Markets).Prior to joining Bajaj Finserv Mutual Fund, he has worked with Sundaram Mutual Fund and Indian Bank.
- Vinay BafnaMr. Bafna has done MBA, FinancePrior to joining Bajaj Finserv Mutual Fund, he has worked with ICICI Securities Ltd
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months27.87% absolute | ₹60,000 | ₹76,722 | 27.87% | |
| 1 year22.28% annualised | ₹1,20,000 | ₹1,35,515 | 12.93% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.